Abstract:Homozygous mutations in the progranulin gene (GRN) are associated with neuronal ceroid lipofuscinosis 11 (CLN11), a rare lysosomal-storage disorder characterized by cerebellar ataxia, seizures, retinitis pigmentosa, and cognitive disorders, usually beginning between 13 and 25 years of age. This is a rare condition, previously reported in only four families. In contrast, heterozygous GRN mutations are a major cause of frontotemporal dementia associated with neuronal cytoplasmic TDP-43 inclusions. We identified homozygous GRN mutations in six new patients. The phenotypic spectrum is much broader than previously reported, with two remarkably distinct presentations, depending on the age of onset. A childhood/juvenile form is characterized by classical CLN11 symptoms at an early age at onset. Unexpectedly, other homozygous patients presented a distinct delayed phenotype of frontotemporal dementia and parkinsonism after 50 years; none had epilepsy or cerebellar ataxia. Another major finding of this study is that all GRN mutations may not have the same impact on progranulin protein synthesis. A hypomorphic effect of some mutations is supported by the presence of residual levels of plasma progranulin and low levels of normal transcript detected in one case with a homozygous splice-site mutation and late onset frontotemporal dementia. This is a new critical finding that must be considered in therapeutic trials based on replacement strategies. The first neuropathological study in a homozygous carrier provides new insights into the pathological mechanisms of the disease. Hallmarks of neuronal ceroid lipofuscinosis were present. The absence of TDP-43 cytoplasmic inclusions markedly differs from observations of heterozygous mutations, suggesting a pathological shift between lysosomal and TDP-43 pathologies depending on the mono or bi-allelic status. An intriguing observation was the loss of normal TDP-43 staining in the nucleus of some neurons, which could be the first stage of the TDP-43 pathological process preceding the formation of typical cytoplasmic inclusions. Finally, this study has important implications for genetic counselling and molecular diagnosis. Semi-dominant inheritance of GRN mutations implies that specific genetic counseling should be delivered to children and parents of CLN11 patients, as they are heterozygous carriers with a high risk of developing dementia. More broadly, this study illustrates the fact that genetic variants can lead to different phenotypes according to their mono- or bi-allelic state, which is a challenge for genetic diagnosis.

GRN Missense Variants and Familial Alzheimer's Disease: Two Case Reports

GRN deletion in familial frontotemporal dementia showing association with clinical variability in 3 familial cases

Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration

Variability of the clinical phenotype in an Italian family with dementia associated with an intronic deletion in the GRN gene

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg

Two novel variants in GRN: the relevance of CNV analysis and genetic screening in FTLD patients with a negative family history

Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred

Clinical and Molecular Characterization of a Novel Progranulin Deletion Associated with Different Phenotypes

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

The novel GRN g.1159_1160delTG mutation is associated with behavioral variant frontotemporal dementia

Frontotemporal Dementia due to the Novel GRN Arg161GlyfsX36 Mutation

Novel missense progranulin gene mutation associated with the semantic variant of primary progressive aphasia

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

Progranulin Gene Mutations in Chinese Patients with Frontotemporal Dementia: A Case Report and Literature Review

Serum progranulin levels in patients with frontotemporal lobar degeneration and Alzheimer's disease: detection of GRN mutations in a Spanish cohort

A novel frameshift GRN mutation results in frontotemporal lobar degeneration with a distinct clinical phenotype in two siblings: case report and literature review

A novel GRN mutation in an Italian patient with non-fluent variant of primary progressive aphasia at onset: a longitudinal case report

A novel GRN mutation (GRN c.708+6_+9delTGAG) in frontotemporal lobar degeneration with TDP-43-positive inclusions: clinicopathologic report of 6 cases

Case report: TMEM106B haplotype alters penetrance of GRN mutation in frontotemporal dementia family

Homozygous GRN mutations: unexpected phenotypes and new insights into pathological and molecular mechanisms

Intrafamilial clinical phenotypic heterogeneity with progranulin gene p.Glu498fs mutation